Analysts See $0.55 EPS for Endo International plc (ENDP) on May, 8

April 16, 2018 - By Catherine Diaz

Endo International plc (NASDAQ:ENDP) Corporate Logo
During 2017 Q4 the big money sentiment increased to 1.13. That’s change of 0.01, from 2017Q3’s 1.12. 37 investors sold all, 61 reduced holdings as Endo International plc ratio increased. 72 rose positions while 39 funds took positions. Funds hold 203.77 million shares thus 0.47% more from 2017Q3’s 202.81 million shares.
Cornerstone Hldg Llc invested in 0.01% or 117,800 shs. Amer Assets Mgmt Ltd Com invested 0.03% in Endo International plc (NASDAQ:ENDP). Zacks Inv Mngmt reported 179,804 shs. Sei Invests Company accumulated 0% or 2,015 shs. Great West Life Assurance Can accumulated 114,565 shs. Moreover, Assetmark has 0% invested in Endo International plc (NASDAQ:ENDP) for 274 shs. Retail Bank Of America De accumulated 0% or 251,535 shs. 227,190 are held by Amer Group Inc Inc. Northwestern Mutual Wealth Management Commerce reported 0% of its capital in Endo International plc (NASDAQ:ENDP). Rafferty Asset Mngmt Llc holds 0.05% in Endo International plc (NASDAQ:ENDP) or 358,018 shs. Panagora Asset Inc has 9,353 shs for 0% of their capital. Hudson Bay Capital L P owns 0.01% invested in Endo International plc (NASDAQ:ENDP) for 50,000 shs. Macquarie Grp Inc Limited reported 12,800 shs. Moreover, Schroder Investment Mgmt Gru has 0% invested in Endo International plc (NASDAQ:ENDP). Hsbc Public Ltd Liability Corp owns 211,241 shs for 0% of their capital.

Investors wait Endo International plc (NASDAQ:ENDP)’s quarterly earnings on May, 8., Zacks reports. This year’s EPS analyst estimate is expected to be $0.55. That is 55.28 % down compareed to $1.23 EPS for last year. If reported the P/E will be 2.48 with $122.79M profit. After $0.77 EPS was published last quarter, analysts now see negative EPS growth of -28.57 % for Endo International plc. ENDP reached $5.46 on during the last trading session after $0.02 change.Currently Endo International plc is downtrending after 44.86% change in last April 17, 2017. ENDP has also 3.46 million shares volume. ENDP underperformed the S&P500 by 56.41%.

Endo International plc (NASDAQ:ENDP) Ratings Coverage

In total 16 analysts cover Endo International (NASDAQ:ENDP). “Buy” rating has 2, “Sell” are 0, while 14 are “Hold”. 13% are bullish. 23 are the (NASDAQ:ENDP)’s analyst reports since October 17, 2017 according to StockzIntelligence Inc. The stock rating was downgraded by Gabelli to “Hold” on Wednesday, February 28. On Friday, October 20 Stifel Nicolaus maintained the shares of ENDP in report with “Hold” rating. On Tuesday, February 13 the stock of Endo International plc (NASDAQ:ENDP) has “Buy” rating given by FBR Capital. The stock rating was maintained by Cowen & Co with “Hold” on Thursday, November 9. On Friday, February 23 the stock has “Equal-Weight” rating by Barclays Capital. The stock rating was maintained by RBC Capital Markets with “Hold” on Friday, November 10. On Monday, October 30 the stock of Endo International plc (NASDAQ:ENDP) has “Hold” rating given by BMO Capital Markets. On Tuesday, January 2 the firm earned “Hold” rating by Stifel Nicolaus. The company rating was maintained by BMO Capital Markets on Monday, November 13. The company rating was maintained by Canaccord Genuity on Sunday, November 12.

Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide.The company has $1.22 billion market cap. The Company’s U.S.Last it reported negative earnings. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets.

Endo International plc (NASDAQ:ENDP) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.